FLGC: Flora Growth Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.46
Enterprise Value ($M) 7.46
Book Value ($M) 4.51
Book Value / Share 0.23
Price / Book 2.32
NCAV ($M) -1.95
NCAV / Share -0.10
Price / NCAV -5.35

Profitability (mra)
Return on Invested Capital (ROIC) -1.69
Return on Assets (ROA) -0.66
Return on Equity (ROE) -5.07

Liquidity (mrq)
Quick Ratio 0.74
Current Ratio 1.05

Balance Sheet (mrq) ($M)
Current Assets 19.76
Assets 26.23
Liabilities 21.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 59.51
Operating Income -13.21
Net Income -15.91

Cash Flow Statement (mra) ($M)
Cash From Operations -5.03
Cash from Investing 0.20
Cash from Financing 6.49

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-21 13G Empery Asset Management, LP 5.36
12-17 13D/A Starke Clifford 19.10 30.80
12-17 13D/A Vaiman Dany 5.60 52.80
11-14 13G/A Global X Management CO LLC 0.00 -100.00
06-27 13G Rds Private Capital Ii, Lp 9.79

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 8,218 35,004 23.48
2025-04-17 28,641 101,263 28.28
2025-04-16 121,819 254,510 47.86

(click for more detail)

Similar Companies
FBLG – FibroBiologics, Inc. FBRX – Forte Biosciences, Inc.
FENC – Fennec Pharmaceuticals Inc. FTLF – FitLife Brands, Inc.
GALT – Galectin Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io